Insider Trading & Ownership - Martin Tami Tillotson

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Martin Tami Tillotson
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-01-10
Sale
2024-01-12
5:00 pm
SUPERNUS PHARMACEUTICALS INC.SUPNMartin Tami Tillotson
Sr. V.P., Regulatory Affairs
8,000$27.91$223,28085,664
(Direct)
View
2023-08-30
Sale
2023-09-01
5:00 pm
SUPERNUS PHARMACEUTICALS INC.SUPNMartin Tami Tillotson
Sr. V.P., Regulatory Affairs
8,100$32$259,20099,149
(Direct)
View
2023-08-25
Sale
2023-08-29
5:00 pm
SUPERNUS PHARMACEUTICALS INC.SUPNMartin Tami Tillotson
Sr. V.P., Regulatory Affairs
5,135$31.59$162,21585,249
(Direct)
View
2022-08-22
Sale
2022-08-23
5:16 pm
SUPERNUS PHARMACEUTICALS INC.SUPNMartin Tami Tillotson
Sr. V.P., Regulatory Affairs
5,000$35.98$179,90087,220
(Direct)
View
2022-08-04
Sale
2022-08-05
4:31 pm
SUPERNUS PHARMACEUTICALS INC.SUPNMartin Tami Tillotson
Sr. V.P., Regulatory Affairs
5,000$32.98$164,90092,220
(Direct)
View
2021-04-13
Sale
2021-04-14
8:24 pm
SUPERNUS PHARMACEUTICALS INC.SUPNMartin Tami Tillotson
Sr. V.P., Regulatory Affairs
6,250$30.98$193,639101,951
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-02-23
Disposition
2024-02-27
5:00 pm
N/A
N/A
SUPERNUS PHARMACEUTICALS INC.SUPNMartin Tami Tillotson
Sr. V.P., Regulatory Affairs
1,250$090,683
(Direct)
View
2024-02-23
Option Award
2024-02-27
5:00 pm
N/A
N/A
SUPERNUS PHARMACEUTICALS INC.SUPNMartin Tami Tillotson
Sr. V.P., Regulatory Affairs
1,250$090,683
(Direct)
View
2024-02-23
Tax Withholding
2024-02-27
5:00 pm
N/A
N/A
SUPERNUS PHARMACEUTICALS INC.SUPNMartin Tami Tillotson
Sr. V.P., Regulatory Affairs
485$29.0690,683
(Direct)
View
2024-02-22
Disposition
2024-02-26
5:00 pm
N/A
N/A
SUPERNUS PHARMACEUTICALS INC.SUPNMartin Tami Tillotson
Sr. V.P., Regulatory Affairs
750$087,668
(Direct)
View
2024-02-22
Tax Withholding
2024-02-26
5:00 pm
N/A
N/A
SUPERNUS PHARMACEUTICALS INC.SUPNMartin Tami Tillotson
Sr. V.P., Regulatory Affairs
246$27.9487,668
(Direct)
View
2024-02-22
Option Award
2024-02-26
5:00 pm
N/A
N/A
SUPERNUS PHARMACEUTICALS INC.SUPNMartin Tami Tillotson
Sr. V.P., Regulatory Affairs
750$087,668
(Direct)
View
2024-01-10
Exercise
2024-01-12
5:00 pm
N/A
N/A
SUPERNUS PHARMACEUTICALS INC.SUPNMartin Tami Tillotson
Sr. V.P., Regulatory Affairs
8,000$9.2485,664
(Direct)
View
2024-01-10
Exercise
2024-01-12
5:00 pm
N/A
2024-01-21
SUPERNUS PHARMACEUTICALS INC.SUPNMartin Tami Tillotson
Sr. V.P., Regulatory Affairs
8,000$085,664
(Direct)
View
2023-08-30
Exercise
2023-09-01
5:00 pm
N/A
N/A
SUPERNUS PHARMACEUTICALS INC.SUPNMartin Tami Tillotson
Sr. V.P., Regulatory Affairs
8,100$23.9999,149
(Direct)
View
2023-08-30
Exercise
2023-09-01
5:00 pm
N/A
2030-02-21
SUPERNUS PHARMACEUTICALS INC.SUPNMartin Tami Tillotson
Sr. V.P., Regulatory Affairs
8,100$099,149
(Direct)
View
2023-02-22
Disposition(A)
2023-04-12
5:00 pm
N/A
N/A
SUPERNUS PHARMACEUTICALS INC.SUPNMartin Tami Tillotson
Sr. V.P., Regulatory Affairs
750$092,284
(Direct)
View
2023-02-22
Tax Withholding(A)
2023-04-12
5:00 pm
N/A
N/A
SUPERNUS PHARMACEUTICALS INC.SUPNMartin Tami Tillotson
Sr. V.P., Regulatory Affairs
289$38.5792,284
(Direct)
View
2023-02-22
Option Award(A)
2023-04-12
5:00 pm
N/A
N/A
SUPERNUS PHARMACEUTICALS INC.SUPNMartin Tami Tillotson
Sr. V.P., Regulatory Affairs
750$092,284
(Direct)
View
2023-02-23
Option Award
2023-02-27
5:03 pm
N/A
2033-02-23
SUPERNUS PHARMACEUTICALS INC.SUPNMartin Tami Tillotson
Sr. V.P., Regulatory Affairs
25,000$0115,323
(Direct)
View
2023-02-22
Disposition
2023-02-24
5:02 pm
N/A
N/A
SUPERNUS PHARMACEUTICALS INC.SUPNMartin Tami Tillotson
Sr. V.P., Regulatory Affairs
750$092,573
(Direct)
View
2023-02-22
Option Award
2023-02-24
5:02 pm
N/A
N/A
SUPERNUS PHARMACEUTICALS INC.SUPNMartin Tami Tillotson
Sr. V.P., Regulatory Affairs
750$092,573
(Direct)
View
2023-02-16
Exercise
2023-02-21
5:01 pm
N/A
2031-04-30
SUPERNUS PHARMACEUTICALS INC.SUPNMartin Tami Tillotson
Sr. V.P., Regulatory Affairs
1,500$088,720
(Direct)
View
2023-01-12
Option Award
2023-01-17
5:02 pm
N/A
2031-04-30
SUPERNUS PHARMACEUTICALS INC.SUPNMartin Tami Tillotson
Sr. V.P., Regulatory Affairs
1,500$088,720
(Direct)
View
2022-08-22
Exercise
2022-08-23
5:16 pm
N/A
N/A
SUPERNUS PHARMACEUTICALS INC.SUPNMartin Tami Tillotson
Sr. V.P., Regulatory Affairs
5,000$7.987,220
(Direct)
View
2022-08-22
Exercise
2022-08-23
5:16 pm
N/A
2023-02-05
SUPERNUS PHARMACEUTICALS INC.SUPNMartin Tami Tillotson
Sr. V.P., Regulatory Affairs
5,000$087,220
(Direct)
View
2022-08-04
Exercise
2022-08-05
4:31 pm
N/A
N/A
SUPERNUS PHARMACEUTICALS INC.SUPNMartin Tami Tillotson
Sr. V.P., Regulatory Affairs
5,000$7.992,220
(Direct)
View
2022-08-04
Exercise
2022-08-05
4:31 pm
N/A
2023-02-05
SUPERNUS PHARMACEUTICALS INC.SUPNMartin Tami Tillotson
Sr. V.P., Regulatory Affairs
5,000$092,220
(Direct)
View
2022-02-22
Option Award(A)
2022-02-25
5:17 pm
N/A
2032-02-22
SUPERNUS PHARMACEUTICALS INC.SUPNMartin Tami Tillotson
Sr. V.P., Regulatory Affairs
21,000$0108,220
(Direct)
View
2022-02-22
Option Award
2022-02-24
9:22 pm
N/A
2032-02-22
SUPERNUS PHARMACEUTICALS INC.SUPNMartin Tami Tillotson
Sr. V.P., Regulatory Affairs
21,000$0108,220
(Direct)
View
2021-04-13
Exercise
2021-04-14
8:24 pm
N/A
N/A
SUPERNUS PHARMACEUTICALS INC.SUPNMartin Tami Tillotson
Sr. V.P., Regulatory Affairs
6,250$12.98101,951
(Direct)
View
2021-04-13
Exercise
2021-04-14
8:24 pm
N/A
2026-03-01
SUPERNUS PHARMACEUTICALS INC.SUPNMartin Tami Tillotson
Sr. V.P., Regulatory Affairs
6,250$0101,951
(Direct)
View
2021-02-19
Option Award
2021-02-23
6:54 pm
N/A
2031-02-19
SUPERNUS PHARMACEUTICALS INC.SUPNMartin Tami Tillotson
Sr. V.P., Regulatory Affairs
17,000$0103,326
(Direct)
View
2020-02-21
Option Award
2020-02-25
6:33 pm
N/A
2030-02-21
SUPERNUS PHARMACEUTICALS INC.SUPNMartin Tami Tillotson
Sr. V.P., Regulatory Affairs
22,000$0107,279
(Direct)
View

Ownership
2020-02-25
6:31 pm
N/A
N/A
SUPERNUS PHARMACEUTICALS INC.SUPNMartin Tami Tillotson
Sr. V.P., Regulatory Affairs
0$0186,279
(Direct)
View
(A) Indicate amendment filing.